BUY Nephrocare Health Services Limited — MarketSmith India
byMarketSmith IndiaHorizon: 1–3 months15 Sept 2026via LiveMint Buy-or-Sell (topic)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·15 Sept · today
Nephrocare Health Services Limited's subsidiary acquired assets of a dialysis center in the Philippines for PhP 67.2 million (approx. INR 10.25 crores). This acquisition is expected to expand the comp
NSE · Agreements·14 Sept · today
Nephrocare Health Services' wholly-owned subsidiary in Philippines has acquired assets of a dialysis center for PhP 67.2 million (approx. INR 10.25 crores).
BSE · Company Update·14 Sept · today
Past month's volume 1.4× the prior month's average
Technicals · volume·11 Sept · 4d ago
'Buy' Nephrocare Health Services for 16% upside, says ICICI Securities; check share price target
NewsLivemint·10 Sept · 4d ago
Nothing found in this tip’s window yet.
RSI at 74 — overbought territory
Technicals · rsi·15 Sept · today
Nephrocare Health Services Limited has informed the exchange about a tax demand arising from a tax audit. This indicates a potential financial liability for the company.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·31 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.